Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

CD137L (soluble) (human), (recombinant)

ALX-522-111-C010 10 µg 246.00 USD
ALX-522-111-3010 3x10 µg SuperPack 517.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-522-032

Biologically active CD137L (4-1BBL; TNFSF 9) comprising the whole extracellular tail domain (aa 49-93), which is important for the cross-linking of the protein that is essential for its biological activity.

Product Details

Alternative Name:4-1BBL, TNFSF 9
Source:Produced in HEK 293 cells. The extracellular domain of human CD137L (aa 49-254) is fused at the N-terminus to a linker peptide (10 aa) and a FLAG®-tag.
UniProt ID:P41274
Concentration:0.1mg/ml after reconstitution.
Formulation:Lyophilized. Contains PBS, 5% trehhalose, and 5% mannitol.
Purity:≥85% (SDS-PAGE)
Endotoxin Content:≤1EU/µg purified protein (LAL test; Bio Whittaker).
Specificity:Binds to human CD137 (4-1BB).
Reconstitution:Reconstitute with 100µl sterile distilled water. Further dilutions should be made with medium containing 5% fetal calf serum.
Shipping:Blue Ice
Long Term Storage:-20°C
Use/Stability:Stable for at least 6 months after receipt when stored at -20°C.
Handling:Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C.
Scientific Background:The CD137 ligand (CD137L, 4-1BBL) is a member of the tumor necrosis factor (TNF) family. CD137L is a type II, transmembrane protein found on activated macrophages, dendritic cells and mature B cells. The interaction with its receptor 4-1BB induces recruitment of TNF receptor-associated factor 1 (TRAF1) and TRAF2 and interaction with the kinase p56lck. CD137 and CD137L have been reported to be involved in tumor rejection, apoptosis, anti-viral immunity, diabetes, in T and B cell co-stimulation and modulation of the immune response.
Technical Info/Product Notes:FLAG is a registered trademark of Sigma-Aldrich Co.
Regulatory Status:RUO - Research Use Only
CD137L (soluble) (human), (recombinant) image
Figure: Dose-dependent binding of recombinant human soluble CD137L to CD137:Fc (human). Recombinant human CD137L saturates its receptor at a concentration range of 2-4’000ng/ml. Method: Receptor binding assay: a 96-well ELISA plate was coated O/N with 50ng per well of CD137 (human):Fc (human) (rec.) (4-1BB:Fc) (Prod. No. ALX-522-031). After a blocking step, the indicated concentrations of rhsCD137L were added for 1 hour. After extensive washing, Enhancer for Ligands (Prod. No. ALX-804-034) was added for 1 hour. Bound ligand was revealed by a rabbit anti-mouse IgG-HRP (1:1’000 dilution, Jackson Immunoresearch) incubated for 1 hour. OPD (Sigma) was used as a substrate and absorbance was measured at 490nm in an ELISA reader."
Please mouse over
CD137L (soluble) (human), (recombinant) image

Product Literature References

Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity: C. Rabu, et al.; J. Biol. Chem. 280, 41472 (2005), Abstract; Full Text

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
CD137L Recombinant protein
By catalog section:


Technical Service
Customer Service